Video Experimental Relacionado
Updated: Sep 10, 2025
07:38
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
261
PAK4 fosforila y estabiliza el MYC para promover la leucemia mieloide aguda
Ting Xie1,2, Peipei Sun1,2, Hao Huang1,2
1Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430071, Hubei, China.
Cell insight
|August 27, 2025
Resumen
La estabilización de MYC en la leucemia mieloide aguda (LMA) es impulsada por la quinasa 4 activada por p21 (PAK4). La inhibición simultánea de PAK4 y MCL-1 ofrece una terapia dirigida prometedora para la LMA al inducir la muerte celular sinérgica.
Área de la Ciencia:
- En el campo de la oncología
- Biología molecular
- Investigación del cáncer
Sus antecedentes:
- La desregulación del CMI es un factor clave en la leucemia mieloide aguda (LMA).
- La estabilidad de la proteína MYC está regulada por modificaciones posteriores a la traducción, incluida la fosforilación y la ubiquitinación.
- Trabajos anteriores identificaron la fosforilación de MYC Serine 67 (S67) como crítica para la actividad oncogénica en la leucemia linfoblástica aguda de células T (LLAT).
Objetivo del estudio:
- Investigar el papel de la fosforilación de MYC S67 en la LMA.
- Para identificar la quinasa responsable de la fosforilación del MYC S67 en la LMA.
- Explorar estrategias terapéuticas dirigidas a la estabilización de la MYC en la LMA.
Principales métodos:
- Investigó la fosforilación de MYC S67 en líneas celulares de LMA.
- Identificó la quinasa activada por p21 4 (PAK4) como la quinasa que cataliza la fosforilación de MYC S67.
- Utilizó inhibidores de la PAK4 (KPT-9274) y antagonistas de la MCL-1 (S63845) en el tratamiento combinado.
Principales resultados:
- La fosforilación MYC S67 está presente en la LMA y está mediada por PAK4.
- PAK4 se une directamente al MYC, fosforila el S67 e inhibe la ubiquitinación dependiente del FBXW7, estabilizando el MYC.
- La inhibición de PAK4 desestabiliza el MYC y reduce la proliferación de LMA, pero la regulación compensatoria de MCL-1 limita la apoptosis.
- La inhibición combinada de PAK4 y el antagonismo de MCL-1 induce una letalidad sinérgica en las células de LMA.
Conclusiones:
- La estabilización de MYC mediada por PAK4 es un mecanismo crítico en la LMA.
- Dirigirse a PAK4 desestabiliza el MYC y suprime el crecimiento de la LMA.
- La terapia combinada con inhibidores de PAK4 y antagonistas de MCL-1 muestra un potencial terapéutico significativo para la LMA.
Videos de Conceptos Relacionados
01:06Induced Pluripotent Stem Cells
4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.4K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
01:07MAPK Signaling Cascades
6.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K
02:15M-Cdk Drives Transition Into Mitosis
5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
00:50Anaphase Promoting Complex
2.9K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.9K
01:22PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K